Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 20026 - 20050 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cupric oxide	Approved	IPP	3652	downregulated	cupric oxide results in decreased expression of IPP mRNA	1p34.1	A21783
Cupric oxide	Approved	IRS1	3667	downregulated	cupric oxide results in decreased expression of IRS1 mRNA	2q36.3	A21783
Cupric oxide	Approved	ISG20	3669	upregulated	cupric oxide results in increased expression of ISG20 mRNA	15q26.1	A21783
Cupric oxide	Approved	ISY1	57461	upregulated	cupric oxide results in increased expression of ISY1 mRNA	3q21.3	A21783
Cupric oxide	Approved	JDP2	122953	upregulated	cupric oxide results in increased expression of JDP2 mRNA	14q24.3	A21783
Cupric oxide	Approved	KBTBD4	55709	upregulated	cupric oxide results in increased expression of KBTBD4 mRNA	11p11.2	A21783
Cupric oxide	Approved	KBTBD8	84541	upregulated	cupric oxide results in increased expression of KBTBD8 mRNA	3p14.1	A21783
Cupric oxide	Approved	KIF18A	81930	downregulated	cupric oxide results in decreased expression of KIF18A mRNA	11p14.1	A21783
Cupric oxide	Approved	KIF18B	146909	downregulated	cupric oxide results in decreased expression of KIF18B mRNA	17q21.31	A21783
Cupric oxide	Approved	KIF20A	10112	downregulated	cupric oxide results in decreased expression of KIF20A mRNA	5q31.2	A21783
Cupric oxide	Approved	KIF20B	9585	downregulated	cupric oxide results in decreased expression of KIF20B mRNA	10q23.31	A21783
Cupric oxide	Approved	KIF23	9493	downregulated	cupric oxide results in decreased expression of KIF23 mRNA	15q23	A21783
Cupric oxide	Approved	KIFC1	3833	downregulated	cupric oxide results in decreased expression of KIFC1 mRNA	6p21.32	A21783
Cupric oxide	Approved	KLF7	8609	upregulated	cupric oxide results in increased expression of KLF7 mRNA	2q33.3	A21783
Cupric oxide	Approved	KLHL18	23276	upregulated	cupric oxide results in increased expression of KLHL18 mRNA	3p21.31	A21783
Cupric oxide	Approved	KLHL42	57542	downregulated	cupric oxide results in decreased expression of KLHL42 mRNA	12p11.22	A21783
Cupric oxide	Approved	KNSTRN	90417	downregulated	cupric oxide results in decreased expression of KNSTRN mRNA	15q15.1	A21783
Cupric oxide	Approved	LARP4	113251	upregulated	cupric oxide results in increased expression of LARP4 mRNA	12q13.12	A21783
Cupric oxide	Approved	LAT	27040	upregulated	cupric oxide results in increased expression of LAT mRNA	16q13	A21783
Cupric oxide	Approved	LATS2	26524	upregulated	cupric oxide results in increased expression of LATS2 mRNA	13q12.11	A21783
Cupric oxide	Approved	LIMK2	3985	downregulated	cupric oxide results in decreased expression of LIMK2 mRNA	22q12.2	A21783
Cupric oxide	Approved	LMNB1	4001	downregulated	cupric oxide results in decreased expression of LMNB1 mRNA	5q23.2	A21783
Cupric oxide	Approved	LMNB2	84823	downregulated	cupric oxide results in decreased expression of LMNB2 mRNA	19p13.3	A21783
Cupric oxide	Approved	MAFF	23764	upregulated	cupric oxide results in increased expression of MAFF mRNA	22q13.1	A21783
Cupric oxide	Approved	MAFG	4097	upregulated	cupric oxide results in increased expression of MAFG mRNA	17q25.3	A21783

Displaying entries 20026 - 20050 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability